149 filings
ARS
2023 FY
FULC
Fulcrum Therapeutics Inc
19 Apr 24
Annual report to shareholders
4:12pm
DEFA14A
FULC
Fulcrum Therapeutics Inc
19 Apr 24
Additional proxy soliciting materials
4:08pm
DEF 14A
FULC
Fulcrum Therapeutics Inc
Definitive proxy
19 Apr 24
4:05pm
S-8
FULC
Fulcrum Therapeutics Inc
27 Feb 24
Registration of securities for employees
5:18pm
S-3
FULC
Fulcrum Therapeutics Inc
Shelf registration
27 Feb 24
5:12pm
8-K
r41cpa783j1b7
27 Feb 24
Fulcrum Therapeutics Announces Recent Business Highlights and Financial Results
7:01am
8-K
pn7q57243v
7 Nov 23
Fulcrum Therapeutics Announces Recent Business Highlights and Financial Results
7:02am
8-K
bu19p8hizj5a jld8dh0
2 Oct 23
Departure of Directors or Certain Officers
4:01pm
8-K
7wlkpvi2
22 Aug 23
Regulation FD Disclosure
7:01am
8-K
kcd5h 3to67bsq20k
3 Aug 23
Fulcrum Therapeutics Announces Recent Business Highlights and Financial Results
7:05am
8-K
j1775k2nuefruv79 m6k
10 Jul 23
Entry into a Material Definitive Agreement
5:06pm
8-K
sf2bv2eoz1si 7f
9 Jun 23
Amendments to Articles of Incorporation or Bylaws
4:05pm
8-K
60l723 od77phr54c3kl
15 May 23
Fulcrum Therapeutics Announces Recent Business Highlights and Financial Results
7:06am